Delivery Order SPE2DE24D0013-SPE2D626F55B6

The Defense Logistics Agency Medical Supply Chain awarded a $5,334.52 firm fixed-price delivery order to Cepheid Inc. on December 23, 2025, for the XKit Xpert Xpress COVID-19, Flu, RSV + Molecular Biology diagnostic test kit. The delivery order, with an ultimate completion date of December 30, 2025, represents a discrete procurement under the DLA's broader medical supply chain contracting activities. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier of molecular diagnostic solutions. Performance will be completed at Cepheid's Sunnyvale, California facility.

Cepheid Inc., a leading manufacturer of advanced molecular diagnostic systems headquartered in Sunnyvale, California, has established itself as a primary federal supplier of infectious disease testing platforms and reagents across multiple healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds substantial existing indefinite delivery contracts with the VA, including a $32.8 million IDC with VISN 6 extending through September 30, 2030, and a $6.7 million IDC with VISN 17 extending through December 28, 2029, which serve as primary contracting vehicles for ongoing procurement of molecular diagnostic testing capabilities. This delivery order for respiratory pathogen detection kits aligns with Cepheid's core competency in rapid molecular diagnostics and represents continued reliance on the company's GeneXpert diagnostic platform technology across federal healthcare operations.